ALPX

Alopexx, Inc. ALPX

Trading inactive

ALPX
Alopexx, Inc. PHASQ
PhaseBio Pharmaceuticals, Inc. GNBTQ
Generex Biotechnology Corporation ALNAQ
Allena Pharmaceuticals, Inc. SPHS
Sophiris Bio, Inc. IMVIQ
IMV Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALPX PHASQ GNBTQ ALNAQ SPHS IMVIQ
6M 0.00 % -99.90 % -99.86 % -99.00 % 0.00 % -99.92 %
YTD 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % -99.57 %
1Y 0.00 % -99.99 % -99.98 % -99.99 % 0.00 % -100.00 %
3Y 0.00 % -100.00 % -100.00 % -100.00 % 0.00 % -100.00 %
5Y 0.00 % -100.00 % -100.00 % -100.00 % 0.00 % -100.00 %
10Y 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %
From the beginning 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend